---
figid: PMC6678606__cancers-11-00948-g001
figtitle: Stearoyl-CoA desaturase 1 (SCD1) as a molecular target for anticancer therapy
organisms:
- Homo sapiens
pmcid: PMC6678606
filename: cancers-11-00948-g001.jpg
figlink: /pmc/articles/PMC6678606/figure/cancers-11-00948-f001/
number: F1
caption: Stearoyl-CoA desaturase 1 (SCD1) as a molecular target for anticancer therapy.
  SCD1 inhibitors suppress cancer cell proliferation, tumor formation and growth,
  and cancer cell migration, invasion, metastasis, and stemness. SCD1 regulates these
  tumorigenic events indirectly through monounsaturated fatty acids (MUFA) synthesis
  or directly by modulating various signaling pathways (e.g., epidermal growth factor/epidermal
  growth factor receptor (EGF/EGFR) mitogenic pathway, AKT/GSKβ/β-catenin pathway
  for stimulation of the epithelial–mesenchymal transition, and Wnt/β-catenin/Hippo
  pathway for the maintenance of cancer cell stemness). Red arrows indicate the anticancer
  effect of SCD1 inhibition.
papertitle: Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of
  Cancer.
reftext: Zuzanna Tracz-Gaszewska, et al. Cancers (Basel). 2019 Jul;11(7):948.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.6321379
figid_alias: PMC6678606__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC6678606__F1
ndex: f87b36a9-deb6-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6678606__cancers-11-00948-g001.html
  '@type': Dataset
  description: Stearoyl-CoA desaturase 1 (SCD1) as a molecular target for anticancer
    therapy. SCD1 inhibitors suppress cancer cell proliferation, tumor formation and
    growth, and cancer cell migration, invasion, metastasis, and stemness. SCD1 regulates
    these tumorigenic events indirectly through monounsaturated fatty acids (MUFA)
    synthesis or directly by modulating various signaling pathways (e.g., epidermal
    growth factor/epidermal growth factor receptor (EGF/EGFR) mitogenic pathway, AKT/GSKβ/β-catenin
    pathway for stimulation of the epithelial–mesenchymal transition, and Wnt/β-catenin/Hippo
    pathway for the maintenance of cancer cell stemness). Red arrows indicate the
    anticancer effect of SCD1 inhibition.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SCD
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
  - NFKB1
  - ALDH1A1
  - EGF
  - EGFR
  - TERC
  - TECR
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - CCND1
  - MAPK3
  - MAPK1
  - MAPK11
  - MAPK12
  - MAPK13
  - MAPK14
  - MAPK8
  - MAPK9
  - MAPK10
  - PTEN
  - GSK3B
  - EPAS1
  - cancer
  - tumor
---
